SHOW ME

PRESS
Mar 15, 2022

Lyfebulb and CVS Kidney Care® Announce Finalists for 2022 Innovation Challenge in Kidney Disease

Lyfebulb and CVS Kidney Care®, a CVS Health® (NYSE:CVS) company, are pleased to announce 10 finalists for the 2022 …
PRESS
Jan 4, 2022

Lyfebulb Launches IBDLyfe, a Community Engagement Platform for People Affected by Inflammatory Bowel Disease

Tuesday, January 4, 2022 NEW YORK — Lyfebulb, an online digital platform and community that empowers people …
PRESS
Nov 1, 2021

Lyfebulb and CVS Kidney Care® partner to drive innovation and improve access to breakthrough technologies

Monday, November 1, 2021 NEW YORK and WOONSOCKET, RI — Lyfebulb, a patient-empowerment platform that connects patients …
PRESS
Oct 13, 2021

Lyfebulb Announces Hiring of Digital Product Engineering Team

NEW YORK, Oct. 13, 2021 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that bridges the gap between its patient communities and …
PRESS
Sep 13, 2021

Lyfebulb and Arena Pharmaceuticals Announce the Winner of the 2021 Innovation Challenge in Inflammatory Bowel Disease

Atray Dixit, PhD of Coral Genomics has been selected to receive the $25,000 Innovation Award NEW YORK, …
PRESS
Jun 29, 2021

Lyfebulb and Arena Pharmaceuticals Announce the Finalists for the 2021 Imagining Life Without Limits – An Inflammatory Bowel Disease Innovation Challenge

Finalists will compete for a $25,000 award NEW YORK, NY, USA – June 29, 2021 – Lyfebulb, …
PRESS
May 14, 2021

Lyfebulb and CSL Behring Announce the Winner of the 2021 Transplant Innovation Challenge

Dr. Minnie Sarwal of NephroSant has been selected to receive the $25,000 Innovation Award NEW YORK, NY, …
PRESS
Apr 8, 2021

Lyfebulb and Arena Pharmaceuticals Seek Applicants for the 2021 Imagining Life Without Limits – An Inflammatory Bowel Disease Innovation Challenge

Winning Entry to Receive $25,000 Award NEW YORK, NY, USA – April 8, 2021 – Lyfebulb, a …
PRESS
Mar 24, 2021

Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge

Finalists will compete for a $25,000 award NEW YORK, NY and KING OF PRUSSIA, PA, USA – …
PRESS
Mar 11, 2021

Lyfebulb and Bristol Myers Squibb Announce the Winner of the 2021 Innovation Challenge in Multiple Sclerosis

Evolution Devices has been awarded the $25,000 Innovation Award for its smart stimulation therapy to improve the …
PRESS
Feb 9, 2021

Lyfebulb and Bristol Myers Squibb Announce the Finalists for the 2021 MS Innovation Challenge

Ten patient entrepreneurs have been shortlisted as finalists in the Lyfebulb and Bristol Myers Squibb “Addressing Unmet …
PRESS
Feb 8, 2021

Lyfebulb Initiative to Help Organ Transplant Recipients Access Innovative Solutions to Improve Daily Lives

Winner of Innovation Challenge to Receive $25,000 Grant NEW YORK, NY, USA – February 8, 2021 – …